BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
34 hedge funds and large institutions have $5.76M invested in Bellicum Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
34
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.76M | |
| 2 | +$563K | |
| 3 | +$350K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$235K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$187K |
Top Sellers
| 1 | -$691K | |
| 2 | -$469K | |
| 3 | -$362K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$190K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$91K |